Cyber Monday Deal: Up to 60% off InvestingProCLAIM SALE

Woman arrested for threatening to kill Texas federal judge in abortion pill case

Published 11/08/2023, 05:14 PM
Updated 11/08/2023, 06:11 PM

By Brendan Pierson

(Reuters) - A woman was arrested in Florida on Wednesday on charges that she threatened to kill a Texas federal judge who earlier this year suspended approval of the abortion drug mifepristone, according to court records.

Alice Marie Pence placed a call from Florida to the chambers of a federal judge in Amarillo, Texas, federal court around March 12 and threatened to kill him, according to a grand jury indictment. Though he was not named in the indictment, the only federal judge in Amarillo is U.S. District Judge Matthew Kacsmaryk.

Pence is charged with one count of threatening interstate communication and one count of influencing a federal official by threat. The indictment, filed in Kacsmaryk's court, says the threat was in retaliation for the judge's performance of his official duties.

A lawyer for Pence could not immediately be identified. Kacsmaryk and a spokesperson for Texas federal prosecutors did not immediately respond to requests for comment.

Kacsmaryk held a hearing on anti-abortion groups' bid to ban mifepristone on March 15. He had told lawyers in the case before the hearing that his chambers had received death threats.

Kacsmaryk suspended mifepristone's approval in April, effectively banning the drug. However, his order is on hold while the Biden administration appeals to the U.S. Supreme Court, and mifepristone remains available.

© Reuters. FILE PHOTO: Matthew Kacsmaryk, deputy counsel for the First Liberty Institute, answers questions during his nomination hearing by the U.S. Senate Committee on the Judiciary at the Dirksen Senate Office Building in Washington, U.S. December 13, 2017 in a still image from video. Pool via REUTERS/File Photo

Amarillo federal court has become a favored venue for socially conservative groups because it ensures their cases will be heard by Kacsmaryk, a staunch conservative and former Christian activist.

Mifepristone has been approved by the U.S. Food and Drug Administration for use along with another drug, misoprostol, to end pregnancy within the first 10 weeks.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.